Trial Profile
Antitumor Immune Responses of Eribulin in Patients with Locally Advanced or Metastatic Breast Cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 May 2018
Price :
$35
*
At a glance
- Drugs Eribulin (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 08 May 2018 New trial record
- 01 May 2018 Results published in the Anticancer Research